Lindbrook Capital’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$27.7K Sell
1,114
-28
-2% -$667 ﹤0.01% 1216
2024
Q4
$25.9K Buy
1,142
+176
+18% +$3.82K ﹤0.01% 1135
2024
Q3
$20.6K Sell
966
-272
-22% -$5.35K ﹤0.01% 1287
2024
Q2
$23.6K Buy
1,238
+268
+28% +$5.46K ﹤0.01% 1149
2024
Q1
$18.7K Sell
970
-104
-10% -$2.06K ﹤0.01% 1249
2023
Q4
$22.4K Sell
1,074
-84
-7% -$1.61K ﹤0.01% 1123
2023
Q3
$24.9K Buy
1,158
+4
+0.3% +$97 ﹤0.01% 961
2023
Q2
$27.6K Buy
1,154
+12
+1% +$275 ﹤0.01% 934
2023
Q1
$24.3K Buy
1,142
+100
+10% +$1.92K ﹤0.01% 977
2022
Q4
$17K Sell
1,042
-566
-35% -$8.39K ﹤0.01% 1146
2022
Q3
$23K Buy
1,608
+1,240
+337% +$23.4K ﹤0.01% 923
2022
Q2
$9K Buy
368
+80
+28% +$2.39K ﹤0.01% 1293
2022
Q1
$10K Sell
288
-66
-19% -$2.17K ﹤0.01% 1275
2021
Q4
$11K Sell
354
-330
-48% -$10.9K ﹤0.01% 1226
2021
Q3
$24K Sell
684
-82
-11% -$3.2K 0.01% 678
2021
Q2
$32K Buy
766
+70
+10% +$2.8K 0.01% 617
2021
Q1
$26K Sell
696
-92
-12% -$3.48K 0.01% 659
2020
Q4
$33K Buy
788
+92
+13% +$3.83K 0.01% 529
2020
Q3
$30K Sell
696
-28
-4% -$1.21K 0.01% 486
2020
Q2
$31K Sell
724
-79
-10% -$3.12K 0.01% 477
2020
Q1
$26K Buy
803
+644
+405% +$23.9K 0.01% 467
2019
Q4
$6K Sell
159
-574
-78% -$20.4K ﹤0.01% 1057
2019
Q3
$25K Sell
733
-48
-6% -$1.7K 0.01% 638
2019
Q2
$30K Buy
781
+484
+163% +$19.2K 0.01% 570
2019
Q1
$12K Sell
297
-368
-55% -$13.7K ﹤0.01% 841
2018
Q4
$21K Buy
+665
New +$26.8K 0.01% 597

Other funds holding FMS

Lindbrook Capital's FMS Position: Q1 2025 in Review

Lindbrook Capital reduced its Fresenius Medical Care (FMS) stake by 2.5% in Q1 2025, selling an estimated $667 and leaving 1,114 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1216.

Lindbrook Capital first reported a position in FMS in Q4 2018 and has held it in 26 quarters since. The position peaked at $33K in Q4 2020. 202 funds tracked by Wall St. Rank hold FMS as of Q1 2025.

  • Lindbrook Capital held 1,114 shares of Fresenius Medical Care worth $27.7K as of Q1 2025.
  • Lindbrook Capital sold 28 Fresenius Medical Care shares in Q1 2025, an estimated $667.
  • Fresenius Medical Care made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1216 holding.
  • Lindbrook Capital first reported a position in Fresenius Medical Care in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's Fresenius Medical Care position peaked at $33K in Q4 2020.
  • 202 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.